Searched for
GENERIC DRUG DUTY
200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Why is market falling today? 7 triggers behind 800-point Sensex fall, Rs 4 lakh crore wealth wipeoutIndian stock markets experienced a decline on Wednesday as tensions in the Middle East escalated. Crude oil prices surged above $92 a barre...
- India's gem and jewellery exports rise 26.5% in June, shining at $2.21 billionIndia's gem and jewellery exports saw a significant rebound in June, increasing by 26.5 percent. Lower international gold prices and improv...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Trump tariffs may stay alive as US set to impose new import taxes by FridayDonald Trump is likely planning new import duties on many nations by Friday. These levies aim to continue his tariff regime after current o...
- Pharma exports to UK may rise up to 10% in FY27 as CETA takes effectIndia's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...
- Generics must not be imperiled over data protection: Satish Reddy, Chairman, Dr Reddy's LaboratoriesDr Reddy's chairman, Satish Reddy, has raised concerns about compromising India's competitive edge in generics for foreign investments. He ...
- Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...
- US tariff a bitter pill for Indian pharmaDonald Trump's tariffs will impact Indian medicine exports. This policy targets branded and patented drugs. Indian generic drug makers face...
- Chill, trimmed pill prices won't hurt usDonald Trump's executive order targeting international consumer price parity for prescription drugs in the US faces implementation challeng...
- Budget 2025: 'Customs waiver on life-saving drugs won't benefit most patients'Despite the import duty waiver on life-saving drugs for rare diseases announced in the union budget, patients might not benefit due to high...
- Fear of duty hike raising drug prices unfoundedThe withdrawal of customs duty exemption on 76 drugs has led to a hue and cry with many doctors claiming this would make these life-saving ...
- Government eyes more NIPERs, pacts with private cos for drug researchThe government plans to step up partnership with private players through NIPERs for drug discovery as it looks to set up more such institut...
- Generic generics may escape proposed trade margins capThe government’s proposed restriction on drug trade margins is likely to exclude products of four industry titans--GlaxoSmithKline, Ranbaxy...
- Drug companies to pay for 'unfair' marginThe government plans to penalise drug makers who pay wholesalers and chemists over and above the ‘fair’ margin notified by it.
- Generics price cut may cause Rs 50-cr revenue loss for govtThe price reduction agreement for generic drugs worked out between the chemicals ministry and the pharmaceutical industry is likely to resu...
- Govt’s margin cut deal with drug cos in limboThe much-publicised agreement between pharmaceutical corporations and chemicals minister Ram Vilas Paswan on cutting trade margins on drugs...
Load More
